Neuroprotective Potential of Carnosine in Cerebrovascular Diseases

被引:0
|
作者
Neelakandan, A. R. [1 ]
Bae, Ok-Nam [2 ,3 ]
Majid, Arshad [4 ]
Burak, Caglayan A. [5 ]
Rajanikant, G. K. [1 ]
机构
[1] Natl Inst Technol Calicut, Sch Biotechnol, Calicut 673601, Kerala, India
[2] Hanyang Univ, Coll Pharm, Ansan 15588, South Korea
[3] Hanyang Univ, Inst Pharmaceut Sci & Technol, Ansan 15588, South Korea
[4] Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, Dept Neurosci, Sheffield S10 2HQ, S Yorkshire, England
[5] Istanbul Medipol Univ, Regenerat & Restorat Med Res Ctr, Ekinciler Cad 19, TR-34810 Istanbul, Turkey
关键词
Carnosine; Ischemic stroke; Hemorrhagic stroke; Vascular dementia; Neuroprotection; CHRONIC CEREBRAL HYPOPERFUSION; ISCHEMIC NEURONAL DAMAGE; WHITE-MATTER DAMAGE; OXIDATIVE STRESS; GLOBAL BURDEN; CELL-DEATH; ENDOGENOUS NEUROPROTECTOR; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; INDUCED NEUROTOXICITY;
D O I
10.1007/s10989-021-10342-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The growing prevalence, the risk of disabilities, and the lack of effective causal or disease-modifying therapies make cerebrovascular disorders a serious burden. Carnosine, an evolutionarily conserved endogenous dipeptide and over-the-counter food supplement, has a wealth of evidence exhibiting potentially neuroprotective effects. It is a natural, multi-functional, non-toxic anti-glycating antioxidant found in high concentrations in human and mammalian muscle and brain tissues. The physiological presence of carnosine in the brain, ability to cross the blood-brain barrier, and evidence from in vitro, and in vivo studies all point to it as a promising neurotherapeutic agent for cerebrovascular disorders. This review is intended to provide a detailed overview of the neuroprotective role of carnosine in cerebrovascular diseases and summarize existing evidence from cell and animal studies.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Neuroprotective Potential of Carnosine in Cerebrovascular Diseases
    A. R. Neelakandan
    Ok-Nam Bae
    Arshad Majid
    Caglayan A. Burak
    G. K. Rajanikant
    International Journal of Peptide Research and Therapeutics, 2022, 28
  • [2] Neuroprotective features of carnosine in oxidative driven diseases
    Bellia, Francesco
    Vecchio, Graziella
    Cuzzocrea, Salvatore
    Calabrese, Vittorio
    Rizzarelli, Enrico
    MOLECULAR ASPECTS OF MEDICINE, 2011, 32 (4-6) : 258 - 266
  • [3] Antioxidant and Neuroprotective Effects of Carnosine: Therapeutic Implications in Neurodegenerative Diseases
    Solana-Manrique, Cristina
    Sanz, Francisco Jose
    Martinez-Carrion, Guillermo
    Paricio, Nuria
    ANTIOXIDANTS, 2022, 11 (05)
  • [4] Antioxidant and neuroprotective actions of resveratrol in cerebrovascular diseases
    Wang, Qing
    Yu, Qi
    Wu, Min
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [5] The use of actovegin in the neuroprotective treatment of patients with cerebrovascular diseases
    Shavlovskaya, O. A.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (06) : 74 - 76
  • [6] Therapeutic Potential of Carnosine and Its Derivatives in the Treatment of Human Diseases
    Chmielewska, Klaudia
    Dzierzbicka, Krystyna
    Inkielewicz-Stepniak, Iwona
    Przybylowska, Maja
    CHEMICAL RESEARCH IN TOXICOLOGY, 2020, 33 (07) : 1561 - 1578
  • [7] Neuroprotective Potential of Ginkgo biloba in Retinal Diseases
    Martinez-Solis, Isabel
    Acero, Nuria
    Bosch-Morell, Francisco
    Castillo, Encarna
    Eugenia Gonzalez-Rosende, Maria
    Munoz-Mingarro, Dolores
    Ortega, Teresa
    Amparo Sanahuja, Maria
    Villagrasa, Victoria
    PLANTA MEDICA, 2019, 85 (17) : 1292 - 1303
  • [8] Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases
    Wu, Haijian
    Niu, Huanjiang
    Shao, Anwen
    Wu, Cheng
    Dixon, Brandon J.
    Zhang, Jianmin
    Yang, Shuxu
    Wang, Yirong
    MARINE DRUGS, 2015, 13 (09): : 5750 - 5766
  • [9] Potential Linkage Between Cerebrovascular Diseases and Metabolic Syndrome
    Jabir, Nasimudeen R.
    Firoz, Chelapram Kandy
    Khan, Mohd. Shahnawaz
    Zaidi, Syed Kashif
    Ashraf, Ghulam Md.
    Shakil, Shazi
    Kamal, Mohammad Amjad
    Tabrez, Shams
    CURRENT DRUG METABOLISM, 2017, 18 (01) : 62 - 68
  • [10] MicroRNAs in Cerebrovascular Diseases - from Pathophysiology to Potential Biomarkers
    Volny, O.
    Kasickova, L.
    Coufalova, D.
    Cimflova, P.
    Novak, J.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2016, 79 (03) : 287 - 293